Latest Stock Split Details
Key information about Paradigm Biopharmaceuticals Limited's most recent stock split
Split Date: 2023-11-01
Split Ratio: 257:250
Price Before Split: $0.44
Price After Split: $0.43
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.03 times more shares (a 257:250 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Paradigm Biopharmaceuticals Limited's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2023-11-01 | 257:250 | No | $0.44 | $0.43 |
About Paradigm Biopharmaceuticals Limited
Company overview and industry information
Paradigm Biopharmaceuticals Limited (PBIGF) operates in the Biotechnology industry. The recent 257-for-250 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Biotechnology
Go to Paradigm Biopharmaceuticals Limited Summary